A number of retrospective studies have evaluated the role of urinary EGF as a predictive marker for kidney function decline in various clinical settings, such as diabetes mellitus, anti-neutrophil cytoplasmic antibody–associated vasculitis, and CKD in general (14, 26, 27). The gene discussed is EGF; the disease is vasculitis.